Google
Trusted Resources: Community Center
Online groups, photo galleries and blogs
MKSAP: 24-Year-Old Woman With Sickle Cell Anemia
A 24-year-old woman undergoes routine evaluation. She is pregnant at 12 weeks’ gestation. Medical history is notable for homozygous sickle cell anemia (Hb SS). She has had multiple uncomplicated painful crises treated at home with hydration, nonopioid analgesia, and incentive spirometry. She requires hospital management for these episodes approximately twice per year. She has declined the use of hydroxyurea. Her only other medication is folic acid.
+myBinderRelated Content
-
You’d Probably Never Know This Woman’s Had a Debilitating Disease Since BirthCassandra Trimnell was diagnosed with si...
-
Lessons Learned From Building a Pediatric-to-Adult Sickle Cell Transition ProgramObjective: More effective transitions a...
-
Regaining Control: Anxiety in Sickle Cell DiseaseB. was a 15-year-old adolescent girl liv...
-
ASH to develop clinical guidelines to improve care for people with sickle cell diseaseThis World Sickle Cell Day, the American...
-
My medical school lesson was tinged with racism. Did that affect how I treated a sickle cell patient years later?The young woman was curled up in a ball....
-
Kwamie Lassiter FoundationThe mission of the Kwamie Lassiter Found...
-
Phase 3 Trial of Rivipansel in Treating SCD Pain Crisis Fails to Meet Goals, Pfizer AnnouncesThe Phase 3 RESET trial testing the effe...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
